[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"hyperglycaemia-non-diabetic\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:hyperglycaemia-non-diabetic":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,47,78],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":46},"100518034","effects-of-lean-pork-loin-intake-on-protein-homeostasis-and-glucose-regulation-in-prediabetic-adults-100518034",false,"NCT06025292","Effects of Lean Pork Loin Intake on Protein Homeostasis and Glucose Regulation in Prediabetic Adults","PORK","Inclusion Criteria:\n\n* 1\\. Males and females ages 40-65 years.\n* 2\\. BMI 25 to ≤40 kg\u002Fm2 (or body fat % ≥25% in males or ≥36% in females)\n* 3\\. Capable of providing informed consent.\n* 4\\. COVID-19 negative and\u002For asymptomatic.\n* 5\\. Willing to abstain from drinking alcohol or consuming marijuana and CBD products during the 4-day study meal period\n* 6\\. HbA1c: 5.7-6.4% or fasting glucose 100-125 mg\u002FdL\n\nExclusion Criteria:\n\n* 1\\. Participant who does not\u002Fwill not eat animal protein sources.\n* 2\\. Allergy to wheat, soy, or common ingredients in plant-based protein products.\n* 3\\. Body mass index \\\u003C25 kg\u002Fm2 or \\>40 kg\u002Fm2.\n* 4\\. Hemoglobin \\\u003C10g\u002FdL at screening.\n* 5\\. Platelets \\\u003C150,000\u002FuL at screening.\n* 6\\. History of chemotherapy or radiation therapy for cancer in the 6 months prior to enrollment.\n* 7\\. History of gastrointestinal bypass\u002Freduction surgery.\n* 8\\. Pregnant or lactating individuals.\n* 9\\. History of a chronic inflammatory disease (e.g. Lupus, Crohn's disease)\n* 10\\. Currently receiving androgen (e.g., testosterone) or anabolic (e.g., GH, IGF-I) therapy.\n* 11\\. Currently using prescription blood thinning medications.\n* 12\\. Currently using corticosteroid medications (cortisone, hydrocortisone, prednisone, etc.).\n* 13\\. Unable or unwilling to suspend aspirin use for 7 days prior to Visit 3 and Visit 7.\n* 14\\. Unwilling to avoid using protein or amino-acid supplements during participation.\n* 15\\. Unwilling to fast overnight.\n* 16\\. Unwilling to avoid alcohol, marijuana and CBD products for the four study days.\n* 17\\. Participants on glucagon-like-peptide-1 receptor agonist (GLP-1-RA) medications for \\\u003C1 month or with less than one treatment dose (injection) every two weeks","ALL","40 Years","65 Years",{"count":20,"type":21},20,"ESTIMATED","INTERVENTIONAL",[24],"NA","We will be directly comparing a high-quality protein diet composed primarily of lean pork loin (PORK) to a lower-quality plant-based protein diet (PLANT) in individuals with prediabetes on muscle and whole-body protein turnover and glucose regulation.",[27,28],"Hyperglycaemia (Non Diabetic)","Prediabetes",[30,31,32,33],"Lean pork","Muscle Protein Synthesis","Protein","Plant-Based","RECRUITING","2026-06-04",{"date":37,"type":38},"2026-06-08","ACTUAL",{"date":40,"type":38},"2024-09-11",{"date":42,"type":21},"2027-01-31",{"name":44,"class":45},"University of Arkansas","OTHER",1,{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":11,"sex":16,"minAge":54,"maxAge":55,"enrollmentInfo":56,"targetDuration":4,"studyType":22,"phases":57,"briefSummary":58,"conditions":59,"keywords":61,"overallStatus":67,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":77},"100634698","diabetes-prevention-by-group-intervention-and-cgm-use-in-pre-diabetic-adults-100634698","NCT07543068","Diabetes Prevention by Group Intervention and CGM Use in Pre-diabetic Adults","CGM","Inclusion Criteria:\n\n* Diagnosed with Prediabetes by a physician based on A1c, fasting glucose or American Diabetes Association (ADA) Type 2 risk test.\n* 18 to 75 years old inclusive.\n\nExclusion Criteria:\n\n* Non-English-Speaking individuals.\n* Diagnosed with Diabetes.\n* Use of glucose lowering medications (GLP-1, Metformin, etc.)\n* Pregnant women.\n* Unwilling to use Continuous Glucose Monitors (CGMs)\n* Unable to assist to the Group meetings in Conroe, TX.","18 Years","75 Years",{"count":20,"type":21},[24],"This study is being done to find better ways to help people with prediabetes prevent or delay the development of type 2 diabetes. Prediabetes means your blood sugar is higher than normal, but not high enough to be diagnosed with diabetes. It is often silent, but without changes in diet and activity, many people progress to a diagnosis of diabetes within a few years.\n\nThe study combines two strategies:\n\n1. Group visits - small, regular meetings where patients learn about healthy eating, physical activity, and stress management.\n2. Continuous Glucose Monitors (CGMs) - small wearable sensors that measure blood sugar all day and show how food, movement, and sleep affect it in real time.\n\nBy bringing these two tools together, the research hopes to help participants better understand their own bodies and make lasting lifestyle changes.\n\nWhat is the purpose of this research?\n\nThe purpose of this research is to find out whether using a CGM device together with group sessions can help people with prediabetes lower their average blood sugar (measured by A1C) and improve confidence in managing their health.",[60,27],"Pre Diabetic",[52,62,63,64,65,66],"Pre Diabetes","Elevated sugar","Hyperglycemia","Hyperglycaemia","Interventions","NOT_YET_RECRUITING","2026-04-15",{"date":70,"type":38},"2026-04-21",{"date":72,"type":21},"2026-04",{"date":74,"type":21},"2026-12",{"name":76,"class":45},"Sam Houston State University",2,{"id":79,"slug":80,"hasResults":11,"nctId":81,"briefTitle":82,"officialTitle":83,"acronym":4,"eligibilityCriteria":84,"healthyVolunteers":85,"sex":16,"minAge":54,"maxAge":4,"enrollmentInfo":86,"targetDuration":88,"studyType":89,"phases":4,"briefSummary":90,"conditions":91,"keywords":95,"overallStatus":67,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":103,"startDateStruct":105,"completionDateStruct":107,"leadSponsor":109,"locationsCount":46},"100631592","validation-of-remote-photoplethysmography-for-non-invasive-estimation-of-blood-glucose-and-hba1c-100631592","NCT07502690","Validation of Remote Photoplethysmography for Non-Invasive Estimation of Blood Glucose and HbA1c","Validation of Remote Photoplethysmography for Non-Invasive Estimation of Blood Glucose and HbA1c in a Community-Based Population in Jakarta","Inclusion Criteria:\n\n1. Adults aged ≥18 years\n2. Willing to participate and provide informed consent\n3. Able to undergo facial scan and blood examination\n4. Stable clinical condition\n\nExclusion Criteria:\n\n1. Facial conditions interfering with rPPG signal (e.g., wounds, deformities)\n2. Use of facial coverings obstructing camera detection\n3. Inability to remain still during facial scan\n4. Incomplete data or withdrawal from study",true,{"count":87,"type":21},300,"1 Day","OBSERVATIONAL","The goal of this observational study is to evaluate whether a non-invasive facial scan technology using remote photoplethysmography (rPPG) can accurately estimate blood glucose and HbA1c levels in adults living in the community in Jakarta. The study focuses on adults aged 18 years and older, including individuals with or without diabetes.\n\nThe main questions it aims to answer are:\n\n1. Can rPPG-based facial scan estimates of blood glucose and HbA1c match results from standard laboratory blood tests?\n2. How well can rPPG identify individuals with high blood sugar or diabetes risk based on established clinical cut-off values?\n\nResearchers will compare results from the rPPG facial scan with standard laboratory measurements of fasting blood glucose and HbA1c to determine how accurate and reliable the technology is for screening purposes.\n\nParticipants will:\n\n1. Provide basic information such as age, sex, and medical history\n2. Undergo a non-invasive facial scan using a smartphone-based system\n3. Have a blood sample taken to measure fasting blood glucose and HbA1c\n4. Complete all assessments during a single study visit\n\nThis study aims to determine whether rPPG can serve as a simple, non-invasive, and accessible tool for early detection and monitoring of diabetes in community settings.",[92,93,27,94],"Diabetes Mellitus","Hyperglycaemia (Diabetic)","Hypoglycaemia",[96,97,98,99,100,101,102],"remote photoplethysmography","rppg","blood glucose","HbA1c","diabetes mellitus","non-invasive monitoring","digital health screening",{"date":104,"type":38},"2026-04-20",{"date":106,"type":21},"2026-03-23",{"date":108,"type":21},"2026-12-30",{"name":110,"class":45},"Tarumanagara University"]